Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do?

@article{Harrison2009RisingCA,
  title={Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do?},
  author={James D Harrison and Ilona Juraskova and Caroline Anderson and Kathryn Nattress and Philip Beale and A. Lopez and Jonathan Carter},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2009},
  volume={19 6},
  pages={
          1037-46
        }
}
OBJECTIVE Clinical uncertainty currently exists for the timing of treatment for women with epithelial ovarian cancer who are under surveillance for their first recurrence and have rising cancer antigen 125 levels. This study ascertained women's preferences for this clinical scenario and the impact of regular surveillance on psychosocial well-being. METHODS Women with a diagnosis of epithelial ovarian cancer who had completed primary treatment and were in surveillance for their first… CONTINUE READING
1 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…